ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NextGen Behavioral Health Suite Integrates Industry-leading Standards for Substance Use Disorders

Expanded Partnership with American Society of Addiction Medicine Increases Access to Quality Care

NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced the integration of the American Society of Addiction Medicine (ASAM) CONTINUUM into the NextGen® Behavioral Health Suite. Considered the industry’s leading standard in addiction assessment and treatment protocol, ASAM’s collaboration with NextGen Healthcare delivers guidelines that assist providers in determining the severity of substance use disorders (SUD) and outlines best practices in addiction management. A partner since 2016, NextGen Healthcare is now helping to expand access to ASAM’s tools in Arizona's public behavioral health system. The program aims to improve adoption of evidence-based quality care for the assessment and treatment of SUDs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230501005189/en/

National Survey on Mental Illness and Substance Use (Graphic: Business Wire)

National Survey on Mental Illness and Substance Use (Graphic: Business Wire)

“ASAM has put decades of effort into raising the standard of care to give patients and their loved ones optimal treatment outcomes,” said David R. Gastfriend, M.D., DFASAM, chief architect of the ASAM CONTINUUM decision toolkit. “Our work with NextGen Healthcare is helping to ensure patients receive the evidence-based care they deserve. This technology can now easily be integrated into routine care – boosting the comprehensiveness of assessment, standardizing placement, streamlining reimbursement approvals, and improving the quality and efficiency of care nationwide.”

ASAM CONTINUUM is an electronic assessment tool that allows clinicians, counselors, and other staff to leverage a computerized clinical decision support system (CDSS) to assess individuals with addictive SUDs and co-occurring conditions.

“ASAM is setting the standard in addiction medicine through clinical guidelines that allow providers to treat the whole patient,” said Srinivas (Sri) Velamoor, NextGen Healthcare chief growth & strategy officer and executive vice president. “The seamless integration of these standards into the NextGen Behavioral Health Suite means that clinicians have the information they need at the point of care. As more states began to require this standard of care, our clients have the solutions they need to deliver the best care possible, as well as comply with regulatory guidelines.”

Preventing, identifying, and treating addiction has never been more crucial. According to a 2021 survey commissioned by the U.S. Department of Health and Human Services (HHS), 46.3 million people aged 12 or older (16.5 percent of the population) are dealing with a substance use disorder.

“When dealing with patients in crisis, having the right technology in place is critical,” said Erica Chestnut-Ramirez, regional vice president at La Frontera EMPACT- Suicide Prevention Center, a NextGen Healthcare client based in Arizona. “NextGen Healthcare is easing the burden on providers so they can focus on what matters most – providing top-notch patient care.”

NextGen Behavioral Health Suite delivers behavioral health and human services across outpatient, residential, community and inpatient settings and is the industry’s only solution to combine these services with comprehensive primary care and oral health data in one integrated solution.

NextGen Healthcare will demonstrate NextGen Behavioral Health Suite featuring ASAM integration at NatCon23, May 1-3 in Los Angeles. Visit booth #821 or stop by the Palm Tree Court to connect with the NextGen Healthcare team. To schedule a meeting at NatCon, visit at nextgen.com.

About NextGen Healthcare, Inc.

NextGen Healthcare, Inc. (Nasdaq: NXGN) is a leading provider of innovative healthcare technology solutions. We are reimagining ambulatory healthcare with award-winning solutions that enable high-performing practices to create healthier communities. We partner with medical, behavioral and oral health providers in their journey toward whole person health and value-based care. Our highly integrated, intelligent and interoperable solutions go beyond EHR and Practice Management to increase clinical quality and productivity, enrich the patient experience and drive superior financial performance. We are on a quest to achieve better healthcare outcomes for all. Learn more at nextgen.com, and follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

About the American Society of Addiction Medicine

ASAM, founded in 1954, is a professional medical society representing over 7,000 physicians, clinicians, and associated professionals in the field of addiction medicine. ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction.

About La Frontera EMPACT- Suicide Prevention Center

EMPACT is committed to working collaboratively with public and private partners to solve community problems. We have the resources and expertise to address issues of behavioral health, housing, family and children’s services, employment, crisis intervention, and community and cultural education. We work hard to build personal responsibility, stabilize families, and assist individuals in achieving their recovery goals – helping to make our communities safer, stronger and healthier.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.